All Sections

Home | Health

EpiPen agrees to pay $1 million for overcharges to NH Medicaid

August 19. 2017 1:47AM
EpiPens manufactured by Mylan (File photo)

CONCORD — New Hampshire will get $1 million as part of a national settlement that state and federal authorities reached with the drug dispenser of the EpiPen and EpiPen Jr., which was accused of underpaying rebates to state medicaid programs, Attorney General Gordon J. MacDonald announced Friday.

Mylan Inc. reached an agreement to pay the state and federal government $465 million in restitution and other recoveries.

The settlement ends charges that Mylan from 2010-17 submitted false statements to the federal Centers for Medicare and Medicaid Services that improperly classified the pen used to treat or control epileptic seizures for patients on the state-federal health insurance program known as Medicaid.

The charges also were that Mylan did not report a best price to federal authorities for the product in violation of its rebate agreement with the states and federal government.

For New Hampshire, the settlement money goes into the general treasury and can be spent for any purpose, officials said.

Courts Health General News Manchester State Government

Follow us on Twitter Follow us on Facebook Follow our RSS feed
Union Leader app for Apple iPad or Android *
Click to download from Apple Apps StoreClick to download from Android Marketplace
* e-Edition subscription required